摘要
轻度认知障碍(MCI)的基础,随着年龄的增加而改变。我们推测,MRI信号轻度认知障碍(MCI)在一个较高的年龄较年轻人会不同。从Sydney记忆和老龄化问题研究以及Sydney百岁老人的选出的研究方法–244参与者(71-103年)被归类为遗忘型MCI、非遗忘型MCI(naMCI)或认知正常(CN)。脑萎缩和白质高信号(WMH)与MCI亚型和年龄相关被广义线性模型研究,并控制混杂因素。减少逻辑回归分析进行确定结构其可最好的区分 aMCI 从CN< 85个人和那些≥85的人体。结果–aMCI与整体皮质体积有关,颞叶内侧结构,与CN相比选择出胼胝体前部的额叶和顶叶区域;这样的关联与年龄无明显变化。最好从CN中辨别aMCI的结构在<85和≥85年龄段人群中不同:在<85人群中为皮层、壳核、海马旁回、楔前叶和额叶皮质,≥85年龄段人群中为海马、三角部、颞极。 naMCI 和 CN之间的差异很小而且在样本中并无意义。WMHs近期没有与MCI亚型显著相关。结论–结构MRI区分aMCI、但不区分naMCI,从老年人中的CN。最好从CN中辨别aMCI的结构在<85和≥85年龄段人群中不同,表明在年长人群中不同的认知障碍的神经病理基础。
关键词: 高龄,阿尔茨海默病,aMCI,脑萎缩, naMCI,结构磁共振成像。
Current Alzheimer Research
Title:Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians
Volume: 13 Issue: 3
Author(s): Zixuan Yang, Wei Wen, Jiyang Jiang, John D. Crawford, Simone Reppermund, Charlene Levitan, Melissa J. Slavin, Nicole A. Kochan and Robyn L. Richmond, Henry Brodaty, Julian N. Trollor, Perminder S. Sachdev
Affiliation:
关键词: 高龄,阿尔茨海默病,aMCI,脑萎缩, naMCI,结构磁共振成像。
摘要: Underpinnings of mild cognitive impairment (MCI) change with increasing age. We hypothesize that MRI signatures of mild cognitive impairment (MCI) would be different at a higher age compared to younger elders. Methods – 244 participants (71-103 years) from the Sydney Memory and Ageing Study and the Sydney Centenarian Study were categorized as amnestic MCI (aMCI), non-amnestic MCI (naMCI) or cognitively normal (CN). Brain “atrophy” and white matter hyper-intensities (WMHs) associated with MCI subtypes and age effects were examined by general linear models, controlling for confounding factors. Reduced logistic regressions were performed to determine structures that best discriminated aMCI from CN in individuals <85 and those ≥85 years. Results – aMCI was associated with smaller volumes of overall cortex, medial temporal structures, anterior corpus callosum, and select frontal and parietal regions compared to CN; such associations did not significantly change with age. Structures that best discriminated aMCI from CN differed however in the <85 and ≥85 age groups: cortex, putamen, parahippocampal, precuneus and superior frontal cortices in <85 years, and the hippocampus, pars triangularis and temporal pole in ≥85 years. Differences between naMCI and CN were small and non-significant in the sample. WMHs were not significantly associated with MCI subtypes. Conclusions – Structural MRI distinguishes aMCI, but not naMCI, from CN in elderly individuals. The structures that best distinguish aMCI from CN differ in those <85 from those ≥85, suggesting different neuropathological underpinnings of cognitive impairment in the very old.
Export Options
About this article
Cite this article as:
Zixuan Yang, Wei Wen, Jiyang Jiang, John D. Crawford, Simone Reppermund, Charlene Levitan, Melissa J. Slavin, Nicole A. Kochan and Robyn L. Richmond, Henry Brodaty, Julian N. Trollor, Perminder S. Sachdev , Structural MRI Biomarkers of Mild Cognitive Impairment from Young Elders to Centenarians, Current Alzheimer Research 2016; 13 (3) . https://dx.doi.org/10.2174/1567205013666151218150534
DOI https://dx.doi.org/10.2174/1567205013666151218150534 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Strategies of Functional Foods Promote Sleep in Human Being
Current Signal Transduction Therapy An Integrated Drug Development Approach Applying Topological Descriptors
Current Computer-Aided Drug Design Editorial: In Silico Studies in Drug Research Against Neurodegenerative Diseases
Current Neuropharmacology Melatonin Therapy of Pediatric Sleep Disorders: Recent Advances, Why it Works, Who are the Candidates and How to Treat
Current Pediatric Reviews Regulators of Platelet cAMP Levels: Clinical and Therapeutic Implications
Current Medicinal Chemistry The New Challenges of Brain PET Imaging Technology
Current Medical Imaging An Overview on Chemistry and Biological Importance of Pyrrolidinone
Current Organic Synthesis Immune Functions of Glia and Neurons in the Central Nervous System
Current Immunology Reviews (Discontinued) Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Employing New Cellular Therapeutic Targets for Alzheimers Disease: A Change for the Better?
Current Neurovascular Research Bioactive Compounds in Some Culinary Aromatic Herbs and Their Effects on Human Health
Mini-Reviews in Medicinal Chemistry In Vitro Evaluation of Potential Hepatotoxicity Induced by Drugs
Current Pharmaceutical Design Carbon-11 Labeled Tracers for In Vivo Imaging of P-Glycoprotein Function: Kinetics, Advantages and Disadvantages
Current Topics in Medicinal Chemistry Histone Acetylation in Neurodevelopment
Current Pharmaceutical Design Damaged Proteins Bearing L-Isoaspartyl Residues and Aging: A Dynamic Equilibrium Between Generation of Isomerized Forms and Repair by PIMT
Current Aging Science Linalool as a Therapeutic and Medicinal Tool in Depression Treatment: A Review
Current Neuropharmacology NMDA Receptor Antagonists as Antidepressant and Antidementia Drugs: Recent Developments and Future Prospects
Current Medicinal Chemistry - Central Nervous System Agents Cooling the Injured Brain: How Does Moderate Hypothermia Influence the Pathophysiology of Traumatic Brain Injury
Current Pharmaceutical Design Characterisation of a Neural Teratogenicity Assay Based on Human ESCs Differentiation Following Exposure to Valproic Acid
Current Medicinal Chemistry Calpain-1 and Calpain-2 in the Brain: Dr. Jekill and Mr Hyde?
Current Neuropharmacology